ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Align Technology to Award Research Programs That Advance Orthodontic and Dental Patient Care

2023 Grant Application Process Now Open for Up to $300,000 in Funding

Align Technology, Inc. (NASDAQ: ALGN) today announced the opening of its 2023 Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $300,000 will be awarded to university faculty for scientific and technological research initiatives to advance patient care in the fields of orthodontics and dentistry. Align Technology’s Research Award Program has funded approximately $2.7 million in research since the program’s inception in 2010.

“The further advancement of the field of dentistry and orthodontics is dependent on top quality university research, which improves our understanding of the science of dentistry and addresses issues that may be encountered during treatment,” said John Morton, Align vice president, product innovation and Technical Fellow. “It is a privilege for Align to be a part of these advancements through funding to researchers all around the globe.”

“Through Align’s annual research award program, we are proud to support orthodontic and dental science research studies that can ultimately improve treatment outcomes,” said Dr. Mitra Derakhshan, Align vice president, global clinical. “As we expand the capabilities of the Align Digital Platform™, our proprietary combination of software, systems and services designed to provide a seamless experience and workflows, we are enabling more clinical and scientific research opportunities through the continuous introduction of digital technologies such as further studies into Near-infrared imaging (“NIRI”) technology, treatment efficiencies related to treatment times and fewer in-person office visits, and insights into treatment effectiveness such as Class II treatment with mandibular advancement. We will continue to leverage insights from research studies to enhance the treatment planning experience and further advance digital scanning and clear aligner therapy acceptance.”

Awards available for dental research at universities are available in the following regions:

  • Americas (US, Canada, Mexico, Central and South America): Four one-year awards of up to US$25,000 each
  • EMEA: Four one-year awards of up to US$25,000 each
  • APAC: Four one-year awards of up to US$25,000 each

Eligible applicants for dental research awards include full-time and part-time faculty involved in dental or scientific research at universities where Invisalign® treatment or the iTero™ scanner is available. All applications are reviewed by an independent academic committee that forwards its recommendations to Align for final selection. Consideration will be given to first-time applications from a university program. Program details, instructions, and application forms for prospective applicants can be found at https://learn.invisalign.com/research-awards-landing-page (for Americas, EMEA and APAC applicants). Research proposals and completed applications must be received by 5:00 p.m. Pacific Time on March 3, 2023. Award recipients will be notified by June 5, 2023.

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 234 thousand doctor customers and is key to accessing Align’s 500 million consumer market opportunity worldwide. Over the past 25 years, Align has helped doctors treat 14 million patients with the Invisalign system and is driving the evolution in digital dentistry through the Align Digital Platform™, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign trained doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
-1.43 (-0.67%)
AAPL  252.29
+4.84 (1.96%)
AMD  233.08
-1.48 (-0.63%)
BAC  51.28
+0.84 (1.67%)
GOOG  253.79
+1.91 (0.76%)
META  716.91
+4.84 (0.68%)
MSFT  513.58
+1.97 (0.39%)
NVDA  183.16
+1.35 (0.74%)
ORCL  291.31
-21.69 (-6.93%)
TSLA  439.31
+10.56 (2.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.